We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXTI icon
2551
AXT Inc
AXTI
$5.13B
$31.7K ﹤0.01%
3,808
-10,920
-74% -$102K
NGNE icon
2552
Neurogene
NGNE
$738M
$31.6K ﹤0.01%
218
-510
-70% -$78.1K
FLL icon
2553
Full House Resorts
FLL
$83.5M
$29.8K ﹤0.01%
2,805
-9,870
-78% -$84.2K
STXS icon
2554
Stereotaxis
STXS
$139M
$28.4K ﹤0.01%
5,283
-14,457
-73% -$109K
YELL
2555
DELISTED
Yellow Corporation Common Stock
YELL
$28.1K ﹤0.01%
4,966
-14,716
-75% -$85.5K
EMWP
2556
DELISTED
Eros Media World PLC
EMWP
$26.3K ﹤0.01%
1,429
-4,583
-76% -$87.5K
ZVRA icon
2557
Zevra Therapeutics
ZVRA
$679M
$22.5K ﹤0.01%
2,415
-9,185
-79% -$92.6K
EOLS icon
2558
Evolus
EOLS
$536M
$21.3K ﹤0.01%
2,791
-10,150
-78% -$105K
BNFT
2559
DELISTED
Benefitfocus, Inc.
BNFT
$21.1K ﹤0.01%
1,898
-7,411
-80% -$90K
NPKI
2560
NPK International
NPKI
$1.19B
$19.2K ﹤0.01%
5,818
-28,813
-83% -$81.4K
BMTX
2561
DELISTED
BM Technologies, Inc.
BMTX
$18.6K ﹤0.01%
+2,086
New +$21.3K
EMKR
2562
DELISTED
Emcore Corp
EMKR
$16.8K ﹤0.01%
224
-1,134
-84% -$90.7K
AWH
2563
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$14.6K ﹤0.01%
300
-1,654
-85% -$102K
SPB icon
2564
Spectrum Brands
SPB
$2.03B
$7.56K ﹤0.01%
79
ET icon
2565
Energy Transfer Partners
ET
$72.1B
$10 ﹤0.01%
1
-3,720,241
-100% -$35.7M
AHT
2566
Ashford Hospitality Trust
AHT
$19.8M
-415
Closed -$189K
AI icon
2567
C3.ai
AI
$1.57B
-8,000
Closed -$500K
AMPY icon
2568
Amplify Energy
AMPY
$182M
-499
Closed -$2.02K
ARDX icon
2569
Ardelyx
ARDX
$1.03B
-32,596
Closed -$247K
CARM
2570
DELISTED
Carisma Therapeutics
CARM
-3,273
Closed -$302K
CRWD icon
2571
CrowdStrike
CRWD
$226B
-10,944
Closed -$688K
CTXR icon
2572
Citius Pharmaceuticals
CTXR
$21M
-2,046
Closed -$178K
DELL icon
2573
Dell
DELL
$313B
-28,007
Closed -$1.41M
FBRX icon
2574
Forte Biosciences
FBRX
$1.57B
-183
Closed -$154K
GTBP icon
2575
GT Biopharma
GTBP
$10.9M
-382
Closed -$178K

Similar funds

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.